Microarray‐based analysis of whole‐genome DNA methylation profiling in early detection of breast cancer
Authors:
- 11 September 2018
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (1) , 658-670
Abstract
Emerging evidence indicated that changes in DNA methylation early in breast cancer (BC) development might be clinically relevant for therapeutic decisions. Through analysis of whole‐genome gene expression microarray and DNA methylation microarray, we explored genes with abnormal DNA methylation in BC for early detection. Firstly, human BC tissues and adjacent non‐cancerous tissues were collected from nine BC patients. Gene expression microarray sequencing was conducted for identifying differentially expressed genes and DNA methylation microarray sequencing for differentially methylated genes in BC. Differentially expressed genes and methylated genes in BC were further explored using the Cancer Genome Atlas database. The correlation between DNA methylation and gene expression was illustrated by multiple comparisons. In other 60 clinical samples, methylation specific polymerase chain reaction (PCR) and reverse transcription quantitative PCR were applied for the methylation of HOXA4 and IGF1 genes in BC and adjacent non‐cancerous tissues. In total, 1680 upregulated genes and 1249 downregulated genes were determined in BC. Chromosome 16 and 17 showed more differentially methylated genes, and DNA methylation level was increased in BC tissues in each gene region. Chromosome 19 showed more differentially methylated genes, and DNA methylation level was increased in BC tissues in the exoniensis 1, untranslated region‐5 and transcriptional start site 200 gene regions. In other 60 clinical samples, HOXA4 and IGF1 in BC tissues presented increased DNA methylation and decreased gene expression in BC. MCF7 cells treated with RG108 showed decreased HOXA4 and IGF1 expressions. It was estimated that HOXA4 and IGF1 were identified with increased DNA methylation and decreased gene expression in BC, which may serve as biomarkers in early BC detection.Keywords
Funding Information
- Sanming Project of Medicine in Shenzen Municipality (SZSM201606088)
- The Science and Technology Project in Shenzhen (2015170)
- The Project of Public Welfare Research and Capacity Building in Guangdong Province in 2015 (2015A020211003)
This publication has 29 references indexed in Scilit:
- Survival of patients with operable breast cancer (Stages I-III) at a Brazilian public hospital - a closer look into cause-specific mortalityBMC Cancer, 2013
- HOXA4Gene Promoter Hypermethylation as an Epigenetic Mechanism Mediating Resistance to Imatinib Mesylate in Chronic Myeloid Leukemia PatientsBioMed Research International, 2012
- DNA methylation profiling in breast cancer discordant identical twins identifies DOK7 as novel epigenetic biomarkerCarcinogenesis, 2012
- FANSe: an accurate algorithm for quantitative mapping of large scale sequencing readsNucleic Acids Research, 2012
- DNA methylation in peripheral blood measured by LUMA is associated with breast cancer in a population‐based studyThe FASEB Journal, 2012
- Serum levels of IGF-I and BRCA penetrance: a case control study in breast cancer familiesFamilial Cancer, 2011
- Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studiesThe Lancet Oncology, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Association between global DNA hypomethylation in leukocytes and risk of breast cancerCarcinogenesis, 2009
- Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatmentSeminars in Cancer Biology, 2009